C55/100

Is Oscar Health Inc (OSCR) a risky stock?

Sector: Insurance Price: $28.41 Composite: 55/100

As of July 27, 2026, Clavix grades Oscar Health Inc (OSCR) C for risk, a composite score of 55 out of 100 on an A+ to F scale, which puts OSCR in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 27, 2026. Clavix regrades every trading day.

The five risk dimensions behind OSCR's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how OSCR scores on each, as of July 27, 2026.

Financial healthbalance sheet, margins, cash flow
66
News sentimentscored, sourced recent coverage
65
Macro exposuresensitivity to rates, dollar, oil
35
Sector resiliencestrength vs the broad market
50
Price stabilitydrawdown and volatility
29

What's moving OSCR's risk right now

Company-specific signals Clavix flags behind OSCR's current grade, drawn from recent news and filings as of July 27, 2026.

Valuation · mixed signal

data of Oscar Health is split. Some call it a bargain on sales but fully priced on returns, and industry notes flag pricing pressure alongside digitalization tailwinds. A 9.1% jump came on ACA growth and insider sales.

Valuation · raising risk

After a 68% gain over 90 days, Oscar Health has pulled back as analysts question whether the rally outran the fundamentals. Some still call it a value pick, but no financial metrics back that claim.

Demand · supporting the grade

Oscar Health posted a 52.60% revenue jump, putting it on growth investors' radar. The stock is being evaluated for whether that rapid pace can hold up in the healthcare technology space.

Recent OSCR news

The latest headlines Clavix ingested for Oscar Health Inc, newest first. These feed the news-sentiment dimension of OSCR's grade.

What a C grade means

On the Clavix A+ to F scale, OSCR's composite of 55 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell OSCR or any security. Grades are risk indicators, not predictions of return. Data may be delayed.